Restructuring

Desjardins Investments is merging and terminating multiple mutual funds. We dissect the strategy, the impact on investors, and a curious move in ESG.

The e-bike maker reports plunging revenues and a pivot to wholesale, but a history of faked safety certifications and fatal fires haunts its recovery plan.

The blockbuster launch of 'Assassin's Creed Black Flag Resynced' provides a glimmer of hope, but can one hit game patch the holes in a company still bailing water?

The Khazzam family office is moving its foundation from Switzerland to the U.S., signaling a shift to structured, high-impact giving in advanced science.

E.W. Scripps is collapsing its local and national TV silos under one leader, Dean Littleton. It's a high-stakes bet on efficiency in a brutal media landscape.

The maker of T-Fal and All-Clad posts a staggering €124M loss, yet its operational results and cash flow are soaring. Is this a sign of collapse or recovery?

A mixed distribution reveals deep operational issues at Permian Basin Royalty Trust, even as a major unitholder pushes a radical plan to transform its future.

Facing a sales chill in Europe from poor weather and weak demand, Husqvarna Group doubles down on restructuring, targeting SEK 3B in savings by 2028.

ArcBest is simplifying its brand and cutting costs by $40M. We decode the signals behind this major move, from customer integration to workforce impact.

Intuit faces a class-action lawsuit after a 20% stock drop. Allegations of misleading statements and $41M in insider sales put a spotlight on executive accountability.

A $17.5M write-down and a shareholder lawsuit reveal a critical lesson for tech firms: production capacity must align with market demand, or investors will pay the price.

Great Southern Bancorp's Q2 earnings dip due to strategic cuts, but a closer look reveals a bank fortifying itself against industry headwinds.

Amid market volatility, Hunting PLC's H1 results reveal a successful pivot to high-growth subsea and tech, but can this momentum offset legacy segment lags?

With revenue down 22% and losses widening, JCTC's Q3 looks grim. But a stronger balance sheet and insider buying hint at a deliberate, high-stakes pivot.

Safi Silver is slashing its warrant price and extending terms in a bold bid for capital, just as a key director resigns. What does this strategic shift mean?

Activist shareholder Brancous LP1 accused Braemar of a 'stealth liquidation.' Now, the REIT is terminating its costly advisory deal, but at what price?

Eupraxia Pharmaceuticals is overhauling its leadership and relocating to major biotech hubs, betting it all on its late-stage pipeline and a pivotal trial.

MAX Surgical names its founder, Dr. Jason Auerbach, CEO. The move signals a new phase of growth, testing if a surgeon-led model can scale without losing its soul.

Alarum Technologies faces an existential threat after FBI seizures. With a third of its staff cut and no answers, the company's future hangs in the balance.

The acclaimed womenswear brand is closing its doors, not in failure, but as a calculated leap to solve fashion's multi-billion dollar returns crisis with AI.